Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer

Estimating the optimal perioperative chemotherapy utilization rate for muscle‐invasive bladder cancer

Abstract Background Identifying optimal chemotherapy (CT) utilization rates can drive improvements in quality of care. We report a benchmarking approach to estimate the optimal rate of perioperative CT for muscle‐invasive bladder cancer (MIBC). Methods The Ontario Cancer Registry and linked treated...

Full description

Bibliographic Details
Main Authors: Safiya Karim, William J. Mackillop, Kelly Brennan, Yingwei Peng, D. Robert Siemens, Monika K. Krzyzanowska, Christopher M. Booth
Format: Article
Language:English
Published: Wiley 2019-10-01
Series:Cancer Medicine
Subjects:
benchmarking
bladder cancer
neoadjuvant chemotherapy
Online Access:https://doi.org/10.1002/cam4.2449

Internet

https://doi.org/10.1002/cam4.2449

Similar Items